-+ 0.00%
-+ 0.00%
-+ 0.00%

KAIROS PHARMA: TO EVALUATE CO'S LEAD ANTIBODY ENV-105 WITH BAYER'S XOFIGO IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

路透·07/22/2026 12:35:02

登錄查看新聞詳情